Jacobs Levy Equity Management, Inc Innoviva, Inc. Transaction History
Jacobs Levy Equity Management, Inc
- $23.9 Billion
- Q1 2025
A detailed history of Jacobs Levy Equity Management, Inc transactions in Innoviva, Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 119,385 shares of INVA stock, worth $2.34 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
119,385Holding current value
$2.34 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding INVA
# of Institutions
256Shares Held
75MCall Options Held
2.3KPut Options Held
2.4K-
Black Rock Inc. New York, NY9.63MShares$188 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.3MShares$123 Million0.0% of portfolio
-
Putnam Investments LLC Boston, MA6.27MShares$123 Million0.14% of portfolio
-
Dimensional Fund Advisors LP Austin, TX4.66MShares$91.2 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny4.56MShares$89.2 Million0.13% of portfolio
About Innoviva, Inc.
- Ticker INVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,706,000
- Market Cap $1.36B
- Description
- Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...